IL125297A0 - Compositions including calcium influx blockers for inhibiting cell growth - Google Patents

Compositions including calcium influx blockers for inhibiting cell growth

Info

Publication number
IL125297A0
IL125297A0 IL12529797A IL12529797A IL125297A0 IL 125297 A0 IL125297 A0 IL 125297A0 IL 12529797 A IL12529797 A IL 12529797A IL 12529797 A IL12529797 A IL 12529797A IL 125297 A0 IL125297 A0 IL 125297A0
Authority
IL
Israel
Prior art keywords
compositions
cell death
influx
influx blocker
agent
Prior art date
Application number
IL12529797A
Other languages
English (en)
Original Assignee
Wellesley Hospital Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellesley Hospital Found filed Critical Wellesley Hospital Found
Publication of IL125297A0 publication Critical patent/IL125297A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12529797A 1996-01-11 1997-01-13 Compositions including calcium influx blockers for inhibiting cell growth IL125297A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58400096A 1996-01-11 1996-01-11
PCT/CA1997/000019 WO1997025063A1 (en) 1996-01-11 1997-01-13 Compositions including calcium influx blockers for inhibiting cell growth

Publications (1)

Publication Number Publication Date
IL125297A0 true IL125297A0 (en) 1999-03-12

Family

ID=24335483

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12529797A IL125297A0 (en) 1996-01-11 1997-01-13 Compositions including calcium influx blockers for inhibiting cell growth

Country Status (13)

Country Link
EP (1) EP0873137B1 (zh)
JP (1) JP2000513708A (zh)
KR (1) KR19990077183A (zh)
CN (1) CN1099296C (zh)
AT (1) ATE245448T1 (zh)
AU (1) AU732012B2 (zh)
BR (1) BR9710942A (zh)
CA (1) CA2242866A1 (zh)
DE (1) DE69723670D1 (zh)
IL (1) IL125297A0 (zh)
PL (1) PL327921A1 (zh)
TR (1) TR199801359T2 (zh)
WO (1) WO1997025063A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000054332A (ko) * 2000-06-01 2000-09-05 김진경 혈관내피세포 성장인자 억제제에 의한 암 치료법
EP1527343A2 (en) * 2002-07-29 2005-05-04 Novartis AG Organic compounds
KR100573881B1 (ko) * 2003-11-29 2006-04-26 장양수 허혈증상 치료제
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN110106146B (zh) * 2019-03-28 2021-04-02 中国人民解放军军事科学院军事医学研究院 化合物富马酸酮替芬在促进干细胞因子合成和分泌中的用途
CN113384551B (zh) * 2021-05-07 2022-03-08 西安交通大学 一种减少肿瘤内过量钙离子的仿生纳米载体的制备方法和应用

Also Published As

Publication number Publication date
TR199801359T2 (xx) 1998-10-21
JP2000513708A (ja) 2000-10-17
EP0873137A1 (en) 1998-10-28
KR19990077183A (ko) 1999-10-25
ATE245448T1 (de) 2003-08-15
WO1997025063A1 (en) 1997-07-17
CA2242866A1 (en) 1997-07-17
AU1362897A (en) 1997-08-01
CN1213315A (zh) 1999-04-07
PL327921A1 (en) 1999-01-04
EP0873137B1 (en) 2003-07-23
CN1099296C (zh) 2003-01-22
BR9710942A (pt) 2000-10-24
DE69723670D1 (de) 2003-08-28
AU732012B2 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
NO921875D0 (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ATE219674T1 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
EP0690722A4 (en) COMPOSITION AND METHOD FOR REDUCING THE TOXICITY OF BIOLOGICALLY ACTIVE FACTORS
ATE227717T1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
IT1147821B (it) Composizione per il trattamento o la prevenzione di stati infiammatoti dell'intestino nei mammiferi e procedimento di preparazione
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
IL125297A0 (en) Compositions including calcium influx blockers for inhibiting cell growth
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
BRPI0013291B8 (pt) uso de uma composiçao de vidro, e, composição de vidro.
TR199801021T2 (xx) Mide-ba��rsak bozukluklar�n�n �nlenmesi ve tedavisi i�in bizmut i�eren bile�imler.
Lam et al. An analysis of dental trauma in a large rural centre (Bunbury, WA) from 2000-2005
UA28113C2 (uk) Спосіб експрес-тестування ефективності реабілітації здоров'я людини